食管癌术后纵隔淋巴结转移的放射治疗  

Radiotherapy for Mediastinal Lymphonodus Matestasis after Cancer of Esophagus Operation

作　　者：卢庆刚[1] 于韬[2] 李霞[1] 何文贵[1] 

机构地区：[1]辽宁省肿瘤医院放疗科,沈阳110042 [2]辽宁省肿瘤医院医学影像科,沈阳110042

出　　处：《中国现代医生》2008年第15期41-42,共2页China Modern Doctor

摘　　要：目的探讨食管癌术后纵隔淋巴结转移三维适形放射治疗的价值。方法36例食管癌手术后发生纵隔淋巴结转移患者,予三维适形放疗。结果近期疗效:完全缓解36.11%(13/36),部分缓解44.44%(16/36),无变化19.44%(7/36),总有效率80.56%(29/36)。发生急性放射性气管炎Ⅰ～Ⅱ级47.22%(17/36)、Ⅲ～Ⅳ级19.44%(7/36);发生急性放射性食管炎Ⅰ～Ⅱ级52.78%(19/36)、Ⅲ～Ⅳ级11.11%(4/36)。结论三维适形放射治疗食管癌术后纵隔淋巴结转移有较好的疗效,患者耐受性较好。Objective To study the value of three dimensional conformal radiotherapy for mediastinal lymphonodus matestasis after cancer of esophagus operation. Methods Use three dimensional conformal radiotherapy to 36 patients for mediastinal lymphonodus matestasis after cancer of esophagus operation. Results Immediate immediate curative effect：complete catabatic 36.11% （13/36）,part catabatic 44.44% （16/36）,no catabatic 19.44% （7/36）,total efficiency 80.56% （29/36）. The rate of radioactive tracheitis Ⅰ -Ⅱ 47.22% （17/36）, Ⅲ - Ⅳ 19.44%（7/36）. The rate of radioactive esophagitis Ⅰ - Ⅱ 52.78%（19/36）. Ⅲ - Ⅳ 11.11%（4/36）. Conclusion Three dimensional conformal radiotherapy have better curative effect and survivalability for mediastinal lymphonodus matestasis after cancer of esophagus operation.

关 键 词：食管癌 纵隔淋巴结转移 三维适形放射治疗 近期疗效 

分 类 号：R815[医药卫生—放射医学]